Janet Woodcock has become the first US FDA official named to the Patient-Centered Outcomes Research Institute's Board of Governors and will lend her clinical trial and drug development expertise to its research agenda.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?